Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)
Phase 2
Completed
- Conditions
- Chronic DiarrheaBile Acid DiarrheaIrritable Bowel Syndrome With DiarrheaBile Acid MalabsorptionFunctional DiarrheaBile Acid Malabsorption Syndrome Type II
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-11-22
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- Michael Camilleri, MD
- Target Recruit Count
- 30
- Registration Number
- NCT05130047
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
- First Posted Date
- 2018-05-14
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Michael Camilleri, MD
- Target Recruit Count
- 136
- Registration Number
- NCT03523273
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation
- First Posted Date
- 2009-12-24
- Last Posted Date
- 2020-09-04
- Lead Sponsor
- Michael Camilleri, MD
- Target Recruit Count
- 36
- Registration Number
- NCT01038687
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath